This involves employees transitioning from regulatory roles within the FDA to high-profile positions in the pharmaceutical industry.
Critics argue that such moves could compromise public health by introducing bias in regulatory practices and oversight. The FDA and the pharmaceutical industry dismissed these fears, emphasizing their stringent ethical guidelines.
However, the FDA does not track the career moves of its employees post departure from the agency. This lack of oversight was highlighted when two health regulators from the fad accepted positions with Moderna, a leading COVID-19 vaccine manufacturer.